Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01391806 | The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving Surgery | completed | — | 145 | Nordlandssykehuset HFOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00629148 | Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00419822 | Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients | completed | N/A | 30 | Legacy Health SystemOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00601159 | Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | completed | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01206881 | Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | completed | Phase 2 | 45 | Herlev HospitalOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00186212 | Alternative Support for Rural and Isolated Women in an HMO | completed | Phase 3 | 150 | Stanford UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 67 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00525096 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | completed | Phase 3 | 157 | ARCAGY/ GINECO GROUPOTHER | 0 | Jun 30, 2011 | clinicaltrials |
| NCT00352378 | Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer | completed | Phase 3 | 209 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00532272 | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | Phase 2 | 78 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00532623 | Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 82 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00737009 | An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment | completed | — | 259 | AstraZenecaINDUSTRY | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00964522 | Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With Chemotherapy | completed | N/A | 266 | Instituto de Salud Carlos IIIOTHER_GOV | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00976365 | Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer | completed | Phase 2 | 60 | Taiwan THL Co.LTd.INDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00110084 | ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Jun 2, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
| NCT00379782 | Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project | completed | N/A | 628 | Queen's Medical CenterOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT01351974 | Sentinel Node Biopsy in Breast Cancer Patients | completed | — | 3,369 | Uppsala UniversityOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT00342056 | Role of Gene Variation in Effectiveness of Gleevec Treatment | completed | — | 100 | National Cancer Institute (NCI)NIH | 2 | May 25, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00523315 | APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)(APOLLO) | completed | — | 862 | AstraZenecaINDUSTRY | 1 | May 20, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT00645866 | Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 2 | 47 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00870168 | Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer | completed | N/A | 60 | Centre Jean PerrinOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00381901 | Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | completed | Phase 3 | 3,400 | National Cancer Institute, FranceOTHER_GOV | 1 | May 13, 2011 | clinicaltrials |
| NCT00771433 | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 2 | 120 | Centre Francois BaclesseOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00898014 | Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer | completed | — | 216 | Institut CurieOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | completed | Phase 3 | 150 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer | completed | Phase 2 | 96 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00497809 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | completed | Phase 2 | 189 | AviGenicsINDUSTRY | 2 | May 3, 2011 | clinicaltrials |
| NCT00236275 | PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer | completed | Phase 3 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00121836 | A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer | completed | Phase 4 | 109 | Hoffmann-La RocheINDUSTRY | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00782366 | Predictive Genetic Risk Assessment Trial(PGT) | completed | — | 26 | Mayo ClinicOTHER | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00016432 | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen | completed | Phase 3 | 1,598 | NSABP Foundation IncNETWORK | 3 | Apr 19, 2011 | clinicaltrials |
| NCT00253539 | Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer | completed | Phase 2 | 3 | The Cleveland ClinicOTHER | 0 | Apr 13, 2011 | clinicaltrials |
| NCT00477139 | A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer | completed | — | 4 | Stanford UniversityOTHER | 1 | Apr 13, 2011 | clinicaltrials |
| NCT00006825 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00009997 | Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jul 21, 2011source: clinicaltrials